NASP Responds to FTC
NASP Responds to FTC Findings and Reiterates Plea: Specialty Pharmacies and Their Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections
15. Januar 2025 12:49 ET | National Association of Specialty Pharmacy (NASP)
Washington, DC, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) issued the following statement after the Federal Trade Commission (FTC) published a second...
NASP Responds to FTC
NASP Responds to FTC Findings and Reiterates Plea: Specialty Pharmacies and Their Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections
15. Januar 2025 11:55 ET | National Association of Specialty Pharmacy (NASP)
Washington, DC, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) issued the following statement after the Federal Trade Commission (FTC) published a second...
NASP Tells Congress
NASP Tells Congress and the Incoming Trump Administration: Pharmacies and Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections
21. Dezember 2024 08:45 ET | National Association of Specialty Pharmacy (NASP)
Washington, DC, Dec. 21, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy issued the following statement: As the non-profit trade organization representing specialty...
NASP Applauds Congre
NASP Applauds Congressional Efforts to Address Anticompetitive Practices that Restrict Patient Access to Their Specialty Pharmacy
18. Dezember 2024 18:03 ET | National Association of Specialty Pharmacy (NASP)
Washington, DC, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) applauds bipartisan leaders in the House and Senate for their hard work to include crucial...
NCPA: We’re on the V
NCPA: We’re on the Verge of Groundbreaking PBM Reforms
17. Dezember 2024 19:38 ET | National Community Pharmacists Association
Alexandria, Va., Dec. 17, 2024 (GLOBE NEWSWIRE) -- The National Community Pharmacists Association (NCPA), which has lobbied for years for fairer prescription reimbursements and pharmacy benefit...
logo.jpg
Samsung Bioepis’ Fourth Quarter 2024 US Biosimilar Market Report Highlights Challenges and Strategies for Biosimilar Adoption
10. Oktober 2024 08:00 ET | Samsung Bioepis
Samsung Bioepis’ Fourth Quarter 2024 US Biosimilar Market Report Highlights Challenges and Strategies for Biosimilar Adoption
AnewHealth_primary_noReg.png
ExactCare and Tabula Rasa HealthCare Rebrand Combined Organization as AnewHealth
10. Juli 2024 07:30 ET | AnewHealth
CLEVELAND, OH and MOORESTOWN, NJ, July 10, 2024 (GLOBE NEWSWIRE) -- ExactCare and Tabula Rasa HealthCare (TRHC) today announced the official launch of their newly combined brand, AnewHealth—a...
Scathing FTC Interim
Scathing FTC Interim Report on PBMs Warrants Further Investigations, Immediate Action by Policymakers and Regulators
09. Juli 2024 13:13 ET | National Community Pharmacists Association
Alexandria, Va., July 09, 2024 (GLOBE NEWSWIRE) -- The interim report published today by the Federal Trade Commission – titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs...
NASP Applauds the Se
NASP Applauds the Senate Finance Chairman for Working to Address Unfair PBM Practices
26. Juni 2024 19:18 ET | National Association of Specialty Pharmacy (NASP)
Washington, DC, June 26, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) thanks U.S. Senate Finance Committee Chairman Ron Wyden (D-OR) for proactively engaging the...
logo-var1-1
Foundation Health Secures $6 Million in Seed Funding to Power the Next Generation of Consumer Healthcare Experiences
11. März 2024 18:02 ET | Foundation Health
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Foundation Health, a pioneering healthcare technology company, today announced the closure of a $6 million seed funding round. Propelling Foundation...